Cervical intraepithelial neoplasia grade 2/3

Clinical trials for Cervical intraepithelial neoplasia grade 2/3 explained in plain language.

Never miss a new study

Get alerted when new Cervical intraepithelial neoplasia grade 2/3 trials appear

Sign up with your email to follow new studies for Cervical intraepithelial neoplasia grade 2/3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New vaccine aims to reverse HPV-Linked cervical changes without surgery

Vaccine Recruiting now

This phase 2 trial tests a DNA vaccine called PVX4 in 138 women with HPV16-related high-grade cervical dysplasia (CIN2/3). The vaccine is given as a shot with a small electrical pulse to help it enter cells. The goal is to see if it can clear the virus and make abnormal cervical …

Matched conditions: CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 2/3

Phase 2 • Sponsor: PapiVax Biotech, Inc. • Aim: Vaccine

Last updated Jun 27, 2026 12:29 UTC

Cervical intraepithelial neoplasia grade 2/3

Get alerted when new Cervical intraepithelial neoplasia grade 2/3 trials appear

New vaccine aims to reverse HPV-Linked cervical changes without surgery